© David Marcey, 2001
I. Introduction
II. Tetramer Structure
III. The Immunoglobulin Fold
IV. Variable Region Structure
V. ReferencesNote: This exhibit is best viewed if the cue buttons ( ) are pressed in sequence and if the viewer does not independently manipulate the molecule on the left.
I. Introduction
To the
left is a model of an intact IgG1 immunoglobulin (Padlan, 1994), which can serve
as a standard as we begin investigating the basics of immunoglobulin structure.
Two identical heavy (H) and two
identical light (L) chains combine to form this Y-shaped antibody molecule
. Before discussing
structural aspects of the H2L2
tetramer, let's examine the light and heavy chains separately.
The heavy chains each have four domains . The amino terminal variable domains (VH)
are at the tips of the Y. These are followed by three constant domains: CH1,
CH2, and the carboxy terminal CH3,
at the base of the Y's stem. A short stretch, the switch,
connects the heavy chain variable and constant regions . The hinge connects CH2
and CH3
(the Fc fragment) to
the remainder of the antibody (the Fab fragments). One Fc
and two identical Fab fragments can be produced
by proteolytic cleavage of the hinge
in an intact antibody molecule .
The light
chains are constructed of two domains, variable
(VL) and constant (CL),
separated by a switch .
II. Tetramer structure
Two disulfide bonds in the hinge region, between cys235 and cys238 pairs, unite the two heavy chains . The light chains are coupled to the heavy chains by two additional disulfide bonds, between cys229s in the CH1 domains and cys214s in the CL domains . Carbohydrate moieties are attached to asn306 of each CH2 , generating a pronounced bulge in the stem of the Y.
These features have profound
functional consequences. The variable regions of both the heavy and light chains
(VH)and (VL))
lie at the tips of the Y, where they are positioned to stereochemically react
with antigen (see below) . The stem of the Y projects in a way to efficiently mediate effector
functions such as the activation of complement. Its CH2
and CH3 domains bulge to facilitate
interaction with effector proteins.
III. The immunoglobulin fold
Each domain in an antibody
molecule has a similar structure of two beta sheets packed tightly against each
other in a compressed antiparallel beta barrel. This conserved structure is
termed the immunoglobulin fold .
At left is an immunoglobulin fold of a CL domain
containing a 3-stranded sheet packed against a
4-stranded sheet.
The
fold is stabilized by hydrogen bonding between the beta strands of each sheet,
by hydrophobic bonding
between residues of opposite sheets in the interior, and by a
disulfide bond between
the sheets . The
3-stranded sheet
comprises strands C, F,
and G, and the
4-stranded sheet
has strands A, B,
E, and D .
The folds of variable domains
have 9 beta strands arranged in two sheets of 4
and 5 strands .
The 5-stranded sheet is structurally homologous
to the 3-stranded sheet of constant domains, but
contains the extra strands C' and C''
. The remainder of the strands (A,
B, C,
D, E,
F, G)
have the same topology and similar structure as their counterparts in constant
domain immunoglobulin folds
. A disulfide
bond links strands B
and F in opposite
sheets, as in constant domains .
IV. Variable region structure
The variable domains of both light and heavy immunoglobulin chains contain three hypervariable loops, or complementarity-determining regions (CDRs) . To your left the three CDRs of a VL domain (CDR1, CDR2, CDR3) can be seen to cluster at one end of the beta barrel. The CDRs are loops that connect beta strands B-C, C'-C'', and F-G of the immunoglobulin fold . The residues in the CDRs vary from one immunoglobulin molecule to the next, imparting antigen specificity to each antibody.
The VL
and VH
domains at the tips of antibody molecules are closely packed (see above) such
that the 6 CDRs (3 on each domain) cooperate in constructing a surface for antigen-specific
binding. This is shown at left for a monoclonal antibody (IgG1)
(Fischmann, et al., 1991). Residues
in all six CDR's (VL
CDR1, CDR2, CDR3
and VH
CDR1, CDR2, CDR3)
project from the distal surface of the antibody tip, in position to recognize
and bind antigen. For further study, see Antibody
Recognition of Antigen.
V. References
Fischmann, T.O., Bentley, G.A., Bhat, T.N., Boulot, G., Mariuzza, R.A., Phillips, S.E.V., Tello, D., and R.J. Poljak (1991). Crystallographic Refinement of the Three-dimensional Structure of the FabD1.3-Lysozyme Complex at 2.5-Å Resolution. J. Biol. Chem. 266: 12915-12920.
Padlan, E. (1994) Anatomy of the Antibody Molecule. Molecular Immunology 31: 169.